WELCOME
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 20,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
| NEWS | CONGRESSES |
|---|
Fresenius Kabi and
Bayer Schering Pharma enter into a Research, Development and License Agreement regarding HESylation® Technology 18.05.2009 
Fresenius SE: Q1 2009: Successful start into 2009 30.04.2009
Fresenius SE: Successful 2008 − Financial targets fully met or exceeded − Positive outlook for 2009 19.02.2009
|
You are warmly invited to our symposium held on Monday, 31.08., during the 31st ESPEN 2009; August 29. - September 01., 2009, Vienna, Austria
Come and visit us at our booth during the 15th ECCO 2009; September 20. - 24., 2009, Berlin, Germany
We would be pleased to welcome you on our booth during ESPR 2009; October 09. - 12., 2009, Hamburg, Germany
|
